Mitsubishi UFJ Trust & Banking’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $35.3M | Sell |
|
|||||
|
2025
Q2 | $28M | Sell |
|
|||||
|
2025
Q1 | $29.9M | Sell |
|
|||||
|
2024
Q4 | $27.5M | Sell |
|
|||||
|
2024
Q3 | $33.1M | Sell |
|
|||||
|
2024
Q2 | $65.2M | Sell |
|
|||||
|
2024
Q1 | $46.6M | Sell |
|
|||||
|
2023
Q4 | $66.8M | Sell |
|
|||||
|
2023
Q3 | $68.5M | Sell |
|
|||||
|
2023
Q2 | $74.7M | Sell |
|
|||||
|
2023
Q1 | $81.7M | Sell |
|
|||||
|
2022
Q4 | $109M | Sell |
|
|||||
|
2022
Q3 | $95M | Buy |
|
|||||
|
2022
Q2 | $69.1M | Buy |
|
|||||
|
2022
Q1 | $76.5M | Sell |
|
|||||
|
2021
Q4 | $79.9M | Sell |
|
|||||
|
2021
Q3 | $91.9M | Sell |
|
|||||
|
2021
Q2 | $84.5M | Sell |
|
|||||
|
2021
Q1 | $73.7M | Sell |
|
|||||
|
2020
Q4 | $70.6M | Sell |
|
|||||
|
2020
Q3 | $80.6M | Sell |
|
|||||
|
2020
Q2 | $84.4M | Sell |
|
|||||
|
2020
Q1 | $63M | Buy |
|
|||||
|
2019
Q4 | $60.9M | Buy |
|
|||||
|
2019
Q3 | $42M | Buy |
|
|||||
|
2019
Q2 | $28.6M | Buy |
|
|||||
|
2019
Q1 | $36.6M | Buy |
|
|||||
|
2018
Q4 | $25.2M | Sell |
|
|||||
|
2018
Q3 | $32.3M | Sell |
|
|||||
|
2018
Q2 | $47.6M | Sell |
|
|||||
|
2018
Q1 | $58.5M | Buy |
|
|||||
|
2017
Q4 | $57.1M | Buy |
|
|||||
|
2017
Q3 | $32.7M | Sell |
|
|||||
|
2017
Q2 | $22.6M | Sell |
|
|||||
|
2017
Q1 | $14.7M | Sell |
|
|||||
|
2016
Q4 | $10.9M | Sell |
|
|||||
|
2016
Q3 | $34.1M | Buy |
|
|||||
|
2016
Q2 | $26.1M | Sell |
|
|||||
|
2016
Q1 | $30M | Buy |
|
|||||
|
2015
Q4 | $20.8M | Buy |
|
|||||
|
2015
Q3 | $11.9M | Buy |
|
|||||
|
2015
Q2 | $17.2M | Buy |
|